The Valley Desk

Clinical trial reportThe New England journal of medicinePublished

Talquetamab-Daratumumab in Relapsed or Refractory Myeloma

22 of 59 authors shown in byline order.

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
The New England journal of medicine
Published
Subject terms
Humans; Multiple Myeloma; Neoplasm Recurrence, Local; Disease Progression; Thalidomide; Dexamethasone; Antineoplastic Combined Chemotherapy Protocols; Antibodies, Bispecific; Antibodies, Monoclonal; Drug Resistance, Neoplasm; Adult; Aged
PubMed ID
42294841
Added to directory
Source checked

Report a correction or request removal